Suppr超能文献

作为将证据转化为个体化医疗策略的工具的优势、劣势、机会和威胁分析(I-SWOT)。

Analysis of Strengths, Weaknesses, Opportunities, and Threats as a Tool for Translating Evidence into Individualized Medical Strategies (I-SWOT).

作者信息

von Kodolitsch Yskert, Bernhardt Alexander M, Robinson Peter N, Kölbel Tilo, Reichenspurner Hermann, Debus Sebastian, Detter Christian

机构信息

German Aorta Centre of Hamburg, Centre of Cardiology and Cardiovascular Surgery, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.

Institute of Medical Genetics and Human Genetics, Charité Universitätsmedizin, Berlin, Germany.

出版信息

Aorta (Stamford). 2015 Jun 1;3(3):98-107. doi: 10.12945/j.aorta.2015.14.064. eCollection 2015 Jun.

Abstract

BACKGROUND

It is the physicians' task to translate evidence and guidelines into medical strategies for individual patients. Until today, however, there is no formal tool that is instrumental to perform this translation.

METHODS

We introduce the analysis of strengths (S) and weaknesses (W) related to therapy with opportunities (O) and threats (T) related to individual patients as a tool to establish an individualized (I) medical strategy (I-SWOT). The I-SWOT matrix identifies four fundamental types of strategy. These comprise "SO" maximizing strengths and opportunities, "WT" minimizing weaknesses and threats, "WO" minimizing weaknesses and maximizing opportunities, and "ST" maximizing strengths and minimizing threats. Each distinct type of strategy may be considered for individualized medical strategies.

RESULTS

We describe four steps of I-SWOT to establish an individualized medical strategy to treat aortic disease. In the first step, we define the goal of therapy and identify all evidence-based therapeutic options. In a second step, we assess strengths and weaknesses of each therapeutic option in a SW matrix form. In a third step, we assess opportunities and threats related to the individual patient, and in a final step, we use the I-SWOT matrix to establish an individualized medical strategy through matching "SW" with "OT". As an example we present two 30-year-old patients with Marfan syndrome with identical medical history and aortic pathology. As a result of I-SWOT analysis of their individual opportunities and threats, we identified two distinct medical strategies in these patients.

CONCLUSION

I-SWOT is a formal but easy to use tool to translate medical evidence into individualized medical strategies.

摘要

背景

将证据和指南转化为针对个体患者的医疗策略是医生的任务。然而,迄今为止,尚无有助于进行这种转化的正式工具。

方法

我们引入对与治疗相关的优势(S)和劣势(W)以及与个体患者相关的机会(O)和威胁(T)的分析,作为建立个体化(I)医疗策略(I-SWOT)的工具。I-SWOT矩阵确定了四种基本策略类型。这些包括“SO”(最大化优势和机会)、“WT”(最小化劣势和威胁)、“WO”(最小化劣势和最大化机会)以及“ST”(最大化优势和最小化威胁)。每种不同的策略类型都可用于个体化医疗策略的考量。

结果

我们描述了I-SWOT的四个步骤,以建立治疗主动脉疾病的个体化医疗策略。第一步,我们确定治疗目标并识别所有基于证据的治疗选择。第二步,我们以SW矩阵形式评估每种治疗选择的优势和劣势。第三步,我们评估与个体患者相关的机会和威胁,最后一步,我们使用I-SWOT矩阵,通过将“SW”与“OT”相匹配来建立个体化医疗策略。作为示例,我们展示了两名患有相同病史和主动脉病变的30岁马凡综合征患者。通过对他们个体机会和威胁的I-SWOT分析,我们在这些患者中确定了两种不同的医疗策略。

结论

I-SWOT是一种将医学证据转化为个体化医疗策略的正式且易于使用的工具。

相似文献

1
Analysis of Strengths, Weaknesses, Opportunities, and Threats as a Tool for Translating Evidence into Individualized Medical Strategies (I-SWOT).
Aorta (Stamford). 2015 Jun 1;3(3):98-107. doi: 10.12945/j.aorta.2015.14.064. eCollection 2015 Jun.
4
Ranking the strategies for Indian medical tourism sector through the integration of SWOT analysis and TOPSIS method.
Int J Health Care Qual Assur. 2017 Oct 9;30(8):668-679. doi: 10.1108/IJHCQA-05-2016-0073.
5
Strengths, Weaknesses, Opportunities, and Threats (SWOT) Analysis of Hemodialysis Electronic Health Record Implementation.
Cureus. 2024 Feb 22;16(2):e54675. doi: 10.7759/cureus.54675. eCollection 2024 Feb.
6
Family Medicine Program in Iran: SWOT Analysis and TOWS Matrix Model.
Iran J Public Health. 2019 Jun;48(6):1140-1148.
7
Intellectual property management at the National Animal Science Research Institute in India: A case study.
Vet World. 2019 Jul;12(7):1070-1077. doi: 10.14202/vetworld.2019.1070-1077. Epub 2019 Jul 20.
8
Exploration of conservation and development strategies with a limited stakeholder approach for local cattle breeds.
Animal. 2019 Dec;13(12):2922-2931. doi: 10.1017/S1751731119001447. Epub 2019 Jun 26.
9
Global cancer surgery in low-resource settings: A strengths, weaknesses, opportunities, and threats analysis.
Cancer. 2023 Mar 1;129(5):671-684. doi: 10.1002/cncr.34630. Epub 2023 Jan 3.

引用本文的文献

7
Strengths-Weaknesses-Opportunities-Threats Analysis for a Pediatric Anesthesia Program.
Pediatr Qual Saf. 2020 Jan 22;5(1):e254. doi: 10.1097/pq9.0000000000000254. eCollection 2020 Jan-Feb.

本文引用的文献

3
Losartan reduces aortic dilatation rate in adults with Marfan syndrome: a randomized controlled trial.
Eur Heart J. 2013 Dec;34(45):3491-500. doi: 10.1093/eurheartj/eht334. Epub 2013 Sep 2.
4
Comparison of aortic root replacement in patients with Marfan syndrome.
Eur J Cardiothorac Surg. 2011 Nov;40(5):1052-7. doi: 10.1016/j.ejcts.2011.02.018. Epub 2011 Mar 23.
7
Misunderstandings, misperceptions, and mistakes.
Evid Based Med. 2007 Feb;12(1):2-3. doi: 10.1136/ebm.12.1.2-a.
9
Guidelines for the diagnosis and management of Marfan syndrome.
Heart Lung Circ. 2007 Feb;16(1):28-30. doi: 10.1016/j.hlc.2006.10.022. Epub 2006 Dec 26.
10
Aortic root growth in men and women with the Marfan's syndrome.
Am J Cardiol. 2005 Nov 15;96(10):1441-4. doi: 10.1016/j.amjcard.2005.06.094. Epub 2005 Oct 5.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验